Recent Finacing
Recent Raise
Aplagon is a clinical-stage biotechnology company developing APAC, a first-in-class antiplatelet and anticoagulant therapeutic platform for thrombo-inflammatory diseases.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
